Venous thromboembolism in African-Americans: A literature-based commentary

Thrombosis Research

Volumn 125, Issue 1, 2010, Pages 12-18

  Hooper, W Craig ^a  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; D DIMER;

AFRICAN AMERICAN; AGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DEEP VEIN THROMBOSIS; DEMOGRAPHY; DIABETES MELLITUS; DNA POLYMORPHISM; ETHNICITY; GENETIC RISK; GENETIC VARIABILITY; GENETICS; INCIDENCE; ISCHEMIC HEART DISEASE; LUNG EMBOLISM; MORTALITY; OBESITY; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; SICKLE CELL; STROKE; VENOUS THROMBOEMBOLISM;

AFRICAN AMERICANS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FORECASTING; HUMANS; INCIDENCE; MINORITY GROUPS; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 76449090331     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.04.019     Document Type: Review

References (83)

1. Cooper E.S. Cardiovascular diseases and stroke in African-American and other racial minorities in the United States; a statement for health professionals-summary and conclusions. Stroke 22 (1991) 568-569
2. Benjamin I.J., Arnett D.K., and Loscalzo J. Discovering the full spectrum of Cardiovascular disease: Minority health summit 2003. Circ 111 (2005) 1339-1349
3. Heit J.A., Cohen A.T., and Anderson Jr. F.A. Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US. Blood 106 11 (2005) abstract #910, p. 267a
4. White R.H. The epidemiology of venous thromboembolism. Circ 107 (2003) I-4-8
5. Hooper W.C., Holman R.C., Heit J.A., and Cobb N. Venous thromboembolism hospitalizations among American-Indians and Alaska Natives. Thromb Res 108 (2003) 273-278
6. Keenan C.R., and White R.H. The effects of race/ethnicity and sex on the risk of venous Thromboembolism. Curr Opin Pulm Med 13 (2007) 377-388
7. White R.H., Zhou H., Murin S., and Harvey D. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Blood Coag Fibrin Cell Haemos 93 (2005) 298-305
8. Klatsky A.l., Armstrong M.A., and Poggi J. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 85 (2000) 1334-1337
9. Stein P.D., Kayali F., Olson R.E., and Milford C.E. Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: Analysis of data from the national Hospital discharge survey and the United States Bureau of the census. Am J Med 116 (2004) 435-442
10. Stein P.D., Kayali F., Olson R.E., and Milford C.E. Pulmonary thromboembolism in American Indians and Alaskan Natives. Arch Intern Med 164 (2004) 1804-1806
11. White R.H., Zhou H., and Romano P.S. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Int Med 128 (1998) 737-740
12. Heit J.A. The epidemiology of venous thromboembolism in the community. Arterio Thromb Vascu Biol 28 (2008) 370-375
13. Anderson F.A., Wheeler H.B., Goldberg R.J., Hosmer D.W., Patwardhan N.A., Jovanovic B., et al. A population-based perspective of the hospital incidence and case-fatlaity rates of deep vein thrombosis and pulmonary embolism. Arch Intern Med 151 (1991) 933-939
14. Agency for Healthcare Research and Quality. Diagnosis and treatment of deep venous thrombosis and pulmonary embolism. Evidence Report/Technology Assessment #68 Jan. 2003.
15. Oger E. Incidence of venous thromboembolism: A community-based study in western France. Thromb Haemost 83 (2000) 657-660
16. Schneider D., Lilfenfeld D.E., and Im W. The epidemiology of pulmonary embolism: racial contrasts in incidence and in-hospital case fatality. J Natl Med Assoc 98 (2006) 1967-1972
17. Aujesky D., Mor M.K., Geng M., Stone R.A., Fine M.J., and Ibrahim S.A. Predicators of early hospital readmission after acute pulmonary embolism. Arch Int Med 169 (2009) 287-293
18. Stein P.D., Beemath A., and Olson R.E. Trends in the incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients. Am J Cardiol 95 (2005) 1525
19. Stein P.D., Kayali F., and Olson R.E. Estimated case fatality rate of pulmonary embolism, 1979-1998. Am J Cardiol 93 (2004) 1197-1199
20. Stein P.D., Kayali F., and Olson R.E. Incidence of venous thromboembolism in infants and children: Data from the national hospital discharge survey. J Pediatr 145 (2004) 563-565
21. Stein P.D., Hull R.D., Kayali F., Olson R.E., Alshab A.K., Meyers F.A., et al. Venous thromboembolism in pregnancy: 21-year trends. Am J Med 117 (2004) 121-124
22. Siddique R.M., Siddique M.I., and Rimm A.A. Trends in pulmonary embolism mortality in the US elderly population: 1984 through 1991. Am J Publ Heal 88 (1998) 478-480
23. Ibrahaim S.A., Stone R.A., Obrosky S., Sartorius J., Fine M.J., and Aujesky D. Racial differences in 30-day morality for pulmonary embolism. Am J Pub Health 96 (2006) 2161-2164
24. Stein P.D., Hull R.D., Kayali F., Ghali W.A., Alshab A.K., and Olson R.E. Venous thromboembolism according to age. Arch Intern Med 164 (2004) 2260-2265
25. Pierre-Paul D., Mureebe L., Gahtan V., and Kerstein M.D. Role of race and sex in diagnosis and one-year follow-up of deep venous thrombosis. Surg Tech Int 13 (2004) 215-218
26. Stein P.D., Patel N.K., Kalra N.K., Petrina M., Savarapu P., Furlong J.W., et al. Estimated incidence of acute pulmonary embolism in a community/teaching general hospital. Chest 121 (2002) 802-805
27. Stein P.D., Patel K.C., Kalra N.K., El Baage T.Y.Y., Savarapu P., Silbergleit A., et al. Deep venous thrombosis in a general hospital. Chest 122 (2002) 960-962
28. Stein P.D., Hull R., Patel K.C., Olson R.E., Ghali W.A., Alshab A.K., et al. Venous thromboembolic disease: Comparison of the diagnostic process in blacks and whites. Arch Intern Med 163 (2003) 1843-1848
29. Aujesky D., Long J.A., Fine M.J., and Ibrahim S.A. African American race was associated with an increased risk of complications following venous thromboembolism. J Clin Epid 60 (2007) 410-416
30. Hooper W.C., Dilley A., Ribeiro M.J.A., Benson J., Austin H., Silva V., et al. A racial difference in the prevalence of the Arg506->Gln mutation. Thromb Res 81 (1996) 577
31. Dilley A., Austin H., Hooper W.C., El-Jamil M., Whitsett C., Wenger N.K., et al. The prevalence of the prothrombin 20210 G to A variant in African-Americans: Infants, venous thrombosis patients, myocardial infarction patients and controls. J Lab Clin 132 (1998) 452
32. Dowling N.F., Austin H., Whitsett C., Dilley A., Evatt B.L., and Hooper W.C. The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. J of Thromb Haemost 1 (2003) 80
33. Austin H., Key N.S., Benson J.M., Lally C., Dowling N.F., Whitsett C., et al. Sickle-cell trait and the risk of venous thromboembolism among African-Americans. Blood 110 (2007) 908-912
34. Heller P., Best W.R., Nelson R.B., and Becktel J. Clinical implications of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency in hospitalized black male patients. N Engl J Med 300 (1979) 1001-1005
35. Austin H., Lally C., Benson J.M., Whitsett C., Hooper W.C., and Key N.S. Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women. Am J Obstet Gynecol 200 6 (2009) 620.e1-620.e3
36. Stein P.D., Beemath A., Meyers F.A., Skaf E., and Olson R.E. Deep vein thrombosis and pulmonary embolism in hospitalized patients with sickle cell disease. Am J Med 119 (2006) 897
37. Austin H., Hooper W.C., Dilley A., Drews C., Renshaw M., Ellingsen D., et al. The prevalence of two genetic traits related to venous thrombosis in whites and African-Americans. Thromb Res 86 (1997) 409
38. Dilley A., Austin H., El-Jamil M., Hooper W.C., Barnhart E., Evatt B., et al. Genetic factors associated with thrombosis in pregnancy in a United States population. Am J Obstet Gynecol 183 (2000) 1271
39. Hira B., Pegoraro R.J., Rom L., and Moodley J. Absence of factor V leiden, thrombomodulin and prothrombin gene variants in Black South African women with pre-eclampsia and eclampsia. BJOG 110 (2003) 327-328
40. Rose N.C., Wang Y.L., Neubert A.G., Roth N.W., Li M., and Wilson R.B. An evaluation of the factor V leiden mutation in a cohort of African-American pregnant women. Prenat Diag 18 (1998) 315-317
41. Zivelin A., Griffin J.H., Pabinger I., Samama M., Conrad J., Brenner B., et al. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood 89 (1997) 397-402
42. Hooper W.C., Dilley A., Austin H., Silva V., Evatt B.L., Rawlins P., et al. Absence of mutations in the factor V Arg306 and factor VIII Arg336 and Arg562 activated protein C cleavage sites in African-Americans with venous thrombosis. Thromb Haemost 79 (1998) 236
43. Lunghi B., Iacoviello L., Gemmati D., Dilasio M.G., Castoldi E., Pinotti M., et al. Detection of new polymorphic markers in the factor V gene: association with factor V levels in plasma. Thromb Haemost 75 (1996) 45-48
44. Bernardi F., Faioni E.M., Castoldi E., Lunghi B., Castaman G., Sacchi E., et al. A factor V genetic component differing from Factor V R506Q contributes to the activated protein C resistance phenotype. Blood 90 (1997) 1552-1557
45. Faioni E.M., Franchi F., Buccuarelli P., Margaglione M., De Stefano V., Castaman G., et al. Coinheritance of HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of Factor V R506Q (Factor V Leiden). Blood 94 (1999) 3062-3066
46. Benson J.M., Ellingsen D., El-Jamil M., Bonduaris M., Dilley A., Evatt B.L., et al. High throughput analysis of two single nucleotide polymorphisms (SNPs) association with thrombosis using a 5'->3' allelic discrimination assay. Thromb Haemost 86 (2001) 1188-1193
47. Hooper W.C., Lally C., Benson J., Dowling N., and Austin H. The relationship between genetic variants in the endothelial C receptor and venous thromboembolism. J Thromb Haemost 3 Suppl 1 (2005) P1926
48. Folsom A.R., Cushman M., Tsai M.Y., Heckbert S.R., and Aleksic N. Prospective study of the G20210A polymorphism in the prothrombin gene, plasma prothrombin concentration and incidence of venous thromboembolism. Am J Hematol 71 (2002) 285-290
49. Zivelin A., Rosenberg N., Faier S., Kornbrot N., Peretz H., Mannhalter C., et al. A single genetic origin for the common prothrombotic G20210A polymorphism in the prothrombin gene. Blood 92 (1998) 1119-1124
50. Warshawsky I., Hren C., Sercia L., Shadrach B., Deithcher S.R., Newton E., et al. Detection of a novel point mutation of the prothrombin position 20209. Diagn Mol Pathol 11 (2002) 152-156
51. Hooper W.C., Roberts S., Dowling N., Austin H., Lally C., and Whitsett C. The prevalence of the prothrombin gene variant C20209T in African-Americans and Caucasians and lack of association with venous thromboembolism. Thromb Res 118 (2006) 767
52. Dilley A., Hooper W.C., Austin H., Wenger N.K., Silva V., Rawlins P., et al. The relationship of three genetic traits to venous thrombosis in an African-American population. Am J Epidemology 147 (1998) 30
53. Hooper W.C., Dowling N.F., Wenger N.K., Dilley A., Ellingsen D., and Evatt B.L. The relationship of venous thromboembolism and myocardial infarction with the renin-angiotensin system in African-Americans. Am J Hematol 70 (2002) 1-8
54. Hooper W.C., Lally C., Austin H., Renshaw M., Dilley A., Wenger N.K., et al. The role of the tPA I/D and PAI-1 4G/5G polymorphisms in African-Americans with a diagnosis of myocardial infarction and venous thromboembolism. Thrombosis Res 99 (2000) 223
55. Schulman S., and Wiman B. The Significance of Hypofibrinolysis for the Risk of Recurrence of Venous Thromboembolism. Duration of Anticoagulation (DURAC) Trial Study Group. Thromb Haemost 75 4 (1996) 607-611
56. 2 polymorphism with myocardial infarction and venous thrombosis in African-Americans. Chest 116 (1999) 880
57. Dilley A., Hooper W.C., El-Jamil M., Renshaw M.A., Wenger K.A., and Evatt B.L. Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C->T677) and cystathione beta synthase (CBS G->A919, CBS T->C833) are not associated with myocardial infarction in African-Americans. Thromb Res 103 (2001) 109
58. Heil S.G., Heijer Den M., Van Der Rijt-Pisa B.J.M., Kluijtmans A.J., and Blom H.J. The 894 G>T variant of endothelial nitric oxide synthase (eNOS) increases the risk of recurrent venous thrombosis through interaction with elevated homocysteine levels. J Thromb Haem 2 (2004) 750-753
59. Brown K.S., Kluijmans L.A.J., Young I.S., Woodside J., Yarnell J.W.G., McMaster D., et al. Genetic evidence that nitric oxide modulates homocysteine. Arterioscler Thromb Vasc Biol 23 (2003) 1014-1020
60. Koster T., Rosendaal F.R., Reitsma P.H., van der Velden P.A., Breit E., and Vandenbroucke J.P. Factor VII and fibrinogen levels as risk factors for venous thrombosis-A case control study of plasma levels and DNA polymorphisms-The Leiden Thrombophilia study (LETS). Thromb Haemost 71 (1994) 719-722
61. Austin H., Hooper W.C., Lally C., Dilley A., Ellingsen D., Wideman C., et al. Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans. J Clin Epidemiology 53 (2000) 997
62. Lally C., Hooper C., Austin H., Pyle M., Ellingsen D., and Kulkarni R. The alpha fibrinogen thr312ala polymorphism and venous thromboembolism in american caucasians and african americans: Tthe GATE study. J Thromb Haemost 5 Supplement 2 (2007) P-W-429
63. Uitte de Willige S., Pyle M.E., Vos H.L., Visser M.C.H., Lally C., Dowling N.F., Hooper W.C., Bertina R.M., and Austin H. Fibrinogen gamma gene 3'-end polymorphisms and risk of venous thromboembolism in the African-American and Caucasian population. Thromb Haemost 101 (2009) 1078-1084
64. Hinds D.A., Stuve L.L., Nilsen G.B., Halperin E., Eskin E., Ballinger D.G., Frazer K.A., and Cox D.R. Whole genome patterns of common DNA variation in three human populations. Science 307 (2005) 1072-1079
65. Cook D.G., Cappuccio F.P., Atkinson R.W., Wicks P.D., Chitolie A., Nakandakare E.R., Sagnella E.R., and Humphries S.E. Ethnic differences in fibrinogen levels: The role of environment factors and the B-fibrinogen gene. Am J Epidemiol 153 (2001) 799-806
66. Reiner A.P., Carty C.L., Carlson C.S., Wan J.Y., Rieder M.J., Smith J.D., et al. Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the coronary artery risk development in young adults (CARDIA) study. J Thromb Haemost 4 (2006) 1279-1287
67. O'Donnell J., Mumford A.D., Manning R.A., and Laffan M. Elevation of FVIII in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost 83 (2000) 10-13
68. Patel R.K., Ford E., Thumpston J., and Arya R. Coagulation factor levels and venous thrombosis in the black population. Thromb Haemost 91 (2004) 828-830
69. Conlan M.G., Folsom A.R., Finch A., Davis C.E., Sorlie P., Marcucci G., et al. Association of factor VIII and von Willebrand factor with age, race, sex and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 70 (1993) 380-385
70. Dowling N.F., Lally C., Miller C.H., Hooper W.C., and Austin H. Associations of Factor VIII (FVIII) and von Willebrand Factor Antigen (VWF:Ag) with Race, Age, ABO Blood Group and Co-Morbid Conditions. J Thromb Haemo 3 Suppl 1 (2005) P0649
71. Tsai A.W., Cushman M., Rosmand W.D., Heckbert S.R., Tracy R.P., Alesksic N., et al. Coagulation factors, inflammation markers, and venous thromboembolism: The Longitudinal Investigation of Thromboembolism Etiology (LITE). Am J Med 113 (2002) 636-642
72. Jerrard-Dunne P., Evans A., McGovern R., Hajat C., Kalra L., Rudd A.G., et al. Ethnic Differences in Markers of Thrombophilia. Stroke 34 (2003) 1821-1827
73. Lange L.A., Reiner A.P., Carty C.L., Jenny N.S., Cushman M., and Lange E.M. Common genetic variants associated with plasma fibrin D-dimer concentration in older European-and African-American adults. J Thromb Haemost 6 (2008) 654-659
74. Lutsey P.L., Cushman M., Steffen L.M., Green D., Barr R.G., Herrington D., et al. Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the Mesa Study. J Thromb Haem 4 (2006) 2629-2634
75. Hooper WC, Austin H, Lally C, Ellingsen D, Dowling NF, Whitsett C. The association between diabetes and venous thromboembolism in African-Americans and Caucasians and the relationship with peroxisome proliferator-activated receptor polymorphisms. Submitted for publication.
76. Gibbons G.H. Physiology, genetics, and cardiovascular disease: focus on African-Americans. J Clin Hyperten 6 4 suppl 1 (2004) 11-18
77. White R.H., and Keenan C.R. Effects of race ethnicity on the incidence of venous thromboembolism. Thromb Res 123 Suppl 4 (2009) S11-18
78. Hooper W.C., Catravas J.D., Heistad D.D., Sessa W.C., and Mensah G.A. Vascular endothelium summary statement I: Health promotion and chronic disease prevention. Vascul Pharmacol 46 (2007) 315
79. Kalar L., Rambaran C., Chowienczyk, Goss D., Hambleton I., Ritter J., et al. Ethnic Differences in Arterial responses and inflammatory markers in Afro-Caribbean and Caucasian subjects. Arterioscler Thromb Vascu Biol 25 (2005) 2362-2367
80. Kalinowski L., Dobrucki I.T., and Malinski T. Race-specific differences in endothelial function. Circul 109 (2004) 2511-2517
81. Silverstein R.L., Bauer K.A., Cushman M., Esmon C.T., Ershler W.B., and Tracy R.P. Venous thrombosis in the elderly: more questions than answers. Blood 110 (2007) 3097-3101
82. Ganz D.A., Glynn R.J., Morun H., Knight E.L., Bohn R.L., and Avorn J. Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism. J Gen Intern Med 15 (2000) 776-781
83. Ibrahim S.A., Kwoh C.K., Harper D.L., and Baker D.W. Racial differences in the utilization of oral anticoagulation therapy in heart failure: a study of elderly hospitalized patients. J Gen Intern Med 15 (2000) 134-137